EPRX

Eupraxia Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↓ 4/10
  • Value↑ 5/10
Eupraxia Pharmaceuticals sales and earnings growth
EPRX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -36.36%
  • FCF Y/Y↑ 99.69%
Eupraxia Pharmaceuticals gross and profit margin trends
EPRX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 0.00%
Eupraxia Pharmaceuticals net debt vs free cash flow
EPRX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Eupraxia Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks